ABN Amro Investment Solutions Reduces Stock Position in Danaher Corporation $DHR

ABN Amro Investment Solutions trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 454,321 shares of the conglomerate’s stock after selling 13,062 shares during the period. Danaher comprises approximately 1.8% of ABN Amro Investment Solutions’ investment portfolio, making the stock its 10th biggest position. ABN Amro Investment Solutions owned approximately 0.06% of Danaher worth $90,074,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of DHR. Norges Bank purchased a new position in Danaher during the second quarter valued at approximately $1,979,503,000. Viking Global Investors LP boosted its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after purchasing an additional 2,455,994 shares during the period. Generation Investment Management LLP increased its position in shares of Danaher by 56.2% during the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after purchasing an additional 1,787,522 shares during the period. Primecap Management Co. CA lifted its stake in Danaher by 924.2% during the second quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock worth $244,815,000 after purchasing an additional 1,118,318 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Danaher by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after purchasing an additional 788,499 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $212.37 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The firm’s fifty day moving average is $228.63 and its 200-day moving average is $215.52. The firm has a market cap of $150.01 billion, a PE ratio of 42.14, a price-to-earnings-growth ratio of 2.87 and a beta of 0.91.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same period in the prior year, the firm posted $2.14 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Wall Street Analyst Weigh In

DHR has been the topic of several research analyst reports. KeyCorp reissued an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Wells Fargo & Company lifted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Guggenheim boosted their price objective on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Argus set a $265.00 target price on Danaher in a research report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. raised their price objective on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Insider Buying and Selling

In other news, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.